Clinical Evidence Generation

About Myomo

Myomo's mission is to restore function and independence to individuals with upper limb paralysis through its innovative MyoPro powered orthosis. The company has achieved commercial-stage status, securing critical Medicare reimbursement and building a growing body of clinical evidence to support adoption. Its strategy centers on a B2B2C model, expanding insurance coverage, and directly engaging clinicians and therapists to identify eligible patients within a large, underserved neurological rehabilitation market.

About Spinal Resources

Spinal Resources Inc. is a commercial-stage medical device company specializing in next-generation spinal fusion hardware. Its flagship technology is the Bezier Parametric Curve Rod, an FDA-cleared implant designed to provide a graduated stiffness transition along the spinal construct, aiming to reduce complications like proximal junctional kyphosis (PJK). The company's product portfolio, which also includes the versatile Swedge™ screw system, targets cost-effective, patient-specific care in deformity and degenerative spinal surgery. SRI appears to be in an early commercial growth phase, leveraging recent regulatory clearances and patent protections to capture market share.

About CQ Medical

CQ Medical is a private, commercial-stage medical device company focused on the radiotherapy positioning market. It offers a comprehensive portfolio of hardware and accessory solutions, such as supine breastboards, head & neck immobilization systems, thermoplastics, and couchtops, designed to improve precision, patient comfort, and workflow efficiency in radiation oncology. The company actively invests in clinical research to validate its products and has formed strategic partnerships, like the one with Radiating Hope, to expand global access to cancer care. Its business model is based on selling capital equipment and disposable/ reusable accessories to hospitals and cancer treatment centers worldwide.

About Prytime Medical

Prytime Medical is a commercial-stage medical device company focused on life-saving hemorrhage control. Its core product line centers on REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) catheters, including the ER-REBOA™ PLUS and the newer pREBOA-PRO™, designed for temporary aortic occlusion in trauma and obstetric emergencies. The company has established a global commercial footprint with distribution partners and emphasizes comprehensive clinical training through its REBOA Academy. Prytime operates in a high-stakes, niche segment of the medical device market, addressing a leading cause of potentially survivable death in trauma.

About Catalyst OrthoScience

Catalyst OrthoScience is a commercial-stage orthopedic device company specializing in next-generation shoulder replacement systems. Founded in 2015 and based in Naples, Florida, the company differentiates itself through its science-driven, bone-preserving implant designs, including its stemless, elliptical humeral head and simplified reverse shoulder system. With a focus on clinical validation and enabling efficiency in ASCs, Catalyst aims to address key challenges in shoulder arthroplasty by offering solutions that promote anatomic restoration and faster patient recovery.

About Aerogen

Aerogen is a privately held, commercial-stage medical device company and a recognized global leader in aerosol drug delivery for acute respiratory care. Founded in 1997 and headquartered in Galway, Ireland, the company has built its business around a patented vibrating mesh nebulizer technology, which it integrates into its own product lines and partners with leading ventilator manufacturers. Its devices, such as the Aerogen Solo and Aerogen Ultra, are used across invasive mechanical ventilation, non-invasive ventilation, high-flow, and self-ventilating therapies, supported by a substantial body of clinical evidence. The company operates in a large and growing market driven by respiratory diseases and critical care needs.

About BioWave

BioWave is a commercial-stage medical device company focused on non-invasive, high-frequency peripheral nerve stimulation for pain relief. Its core technology differentiates from superficial TENS units by delivering stimulation deep to the nerve to block pain signal transmission, offering hours of relief post-treatment. With multiple FDA-cleared products (BioWavePRO, HOME, GO, PENS) and a significant contract with the US Veterans Administration, the company targets the large chronic and acute pain markets, emphasizing drug-free alternatives. BioWave operates as a private company, generating revenue through device sales to providers, patients, and institutional partners.

About Monaghan Medical

Monaghan Medical is a private, commercial-stage leader in the respiratory medical device sector, with a 40+ year history. The company's core business revolves around designing and manufacturing a portfolio of inhalation aids, including valved holding chambers (e.g., AeroChamber series), nebulizers (e.g., AeroEclipse), OPEP devices (e.g., Aerobika), and peak flow meters. It operates with a dual customer model, serving both end patients/caregivers via prescription and major pharmaceutical companies as a drug delivery device partner. With a state-of-the-art aerosol research lab and a strong emphasis on clinical evidence, Monaghan is positioned in the large and growing global market for chronic respiratory disease management.

About Corcym

Corcym is a UK-based, private medical device company founded in 2020, dedicated to the structural heart market. It has assembled a portfolio of established and innovative surgical technologies, such as the Perceval sutureless valve, with a heritage spanning over 50 years through its acquired products. The company operates globally, targeting cardiac surgeons with a customer-centric model focused on professional education and clinical evidence. Its strategy is to become a leading partner to heart surgeons by providing a complete suite of surgical solutions.

Therapeutic Areas